V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240001358 | 240001358 | null | 77.25 | Curative (C) | 2019-06-16 | 2019-06-21 | null | 01 | N | CYTARABINE | 101210729 |
| 240001365 | 240001365 | null | null | null | null | 2019-08-01 | Azacitidine | null | null | AZACITIDINE | 101356488 |
| 240001374 | 240001374 | null | null | null | null | 2019-01-04 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101583756 |
| 240001388 | 240001388 | 1.86 | 50.2 | Palliative (P) | 2019-01-27 | 2019-01-27 | CYTARABINE + DAUNORUBICIN | 02 | N | AML18 TRIAL | 101697027 |
| 240001390 | 240001390 | 1.59 | 0 | Palliative (P) | null | 2019-04-06 | null | 01 | N | DA | 101322637 |
| 240001392 | 240001392 | 0 | 84.4 | Curative (C) | 2017-07-09 | 2017-07-09 | null | 02 | N | CYTARABINE + DAUNORUBICIN | 101180678 |
| 240001395 | 240001395 | null | null | null | null | 2017-12-19 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | null | null | RITUXIMAB | 101315851 |
| 240001396 | 240001396 | null | null | null | null | 2016-04-29 | DABRAFENIB + TRAMETINIB | null | null | IMATINIB | 100172580 |
| 240001399 | 240001399 | 1.72 | 85 | Curative (C) | 2016-08-11 | 2016-08-12 | null | 02 | N | DA | 100168997 |
| 240001400 | 240001400 | 1.8 | 38.9 | Adjuvant (A) | 2019-06-29 | 2019-07-03 | CYTARABINE | 02 | N | CISPLATIN + GEMCITABINE | 101036115 |
| 240001402 | 240001402 | 1.75 | 51.6 | Palliative (P) | 2018-05-10 | 2018-07-06 | AML 19 TRIAL | 02 | N | NOT MATCHED | 100663588 |
| 240001405 | 240001405 | null | null | null | null | 2019-08-06 | Methotrexate intrathecal | null | null | HYDROXYCARBAMIDE | 100762947 |
| 240001421 | 240001421 | 1.85 | 54.9 | null | null | 2018-12-24 | null | 01 | N | CYTARABINE + DAUNORUBICIN | 101812716 |
| 240001439 | 240001439 | null | null | null | null | 2019-09-03 | Triple / Double Intrathecal Therapy + hydrocortisone | null | null | CYTARABINE | 100444294 |
| 240001450 | 240001450 | null | null | null | null | 2019-10-26 | AML MyeChild 01 A Mitozantrone/Cytarabine | null | null | TRANSPLANT FLUDARABINE + MELPHALAN | 101866229 |
| 240001455 | 240001455 | 1.75 | 104.5 | Curative (C) | null | 2020-02-19 | null | 02 | N | CLADRIBINE | 100688788 |
| 240001469 | 240001469 | 1.64 | 64.5 | Curative (C) | 2018-11-19 | 2018-11-19 | DA | 02 | N | CYTARABINE + DAUNORUBICIN | 101619306 |
| 240001481 | 240001481 | 1.55 | 61.7 | Curative (C) | 2018-03-26 | 2018-03-30 | AML 19 TRIAL | 2 | N | CYTARABINE + DAUNORUBICIN | 100294804 |
| 240001487 | 240001487 | 1.6 | null | Curative (C) | null | 2018-03-09 | CHOP R - 21 days | 02 | N | TRIAL UNSPECIFIED | 100399252 |
| 240001489 | 240001489 | null | null | null | null | 2017-05-30 | AML 19 TRIAL | null | null | CNS HGG LOMUSTINE + TEMOZOLOMIDE | 100940549 |
| 240001490 | 240001490 | 1.65 | 74 | Curative (C) | 2018-08-02 | 2018-08-07 | CHOP R - 21 days | 1 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101327451 |
| 240001491 | 240001491 | 1.61 | 68.6 | 03 | 2017-04-01 | 2017-04-01 | AML MyeChild 01 A Mitozantrone/Cytarabine | 1 | N | AML19 TRIAL | 100947943 |
| 240001493 | 240001493 | null | 80.8 | 03 | null | 2019-07-03 | CHLORAMBUCIL + OBINUTUZUMAB | 2 | N | BENDAMUSTINE + RITUXIMAB | 101658883 |
| 240001495 | 240001495 | 1.62 | 86.75 | Palliative (P) | null | 2018-01-21 | DA | 02 | N | FCR | 101184508 |
| 240001509 | 240001509 | 1.6 | 56 | Curative (C) | null | 2017-09-23 | null | 2 | N | DA | 100977463 |
| 240001512 | 240001512 | 1.61 | 89.9 | Palliative (P) | 2017-07-24 | 2017-09-10 | CHOP - 21 days | 02 | N | DA | 101423799 |
| 240001516 | 240001516 | 1.62 | 79.9 | Curative (C) | 2019-11-13 | 2019-11-13 | BENDAMUSTINE + RITUXIMAB | 02 | N | CHLORAMBUCIL | 101418874 |
| 240001526 | 240001526 | null | null | null | null | 2019-12-01 | Hydroxycarbamide | null | null | CHOP R | 100399158 |
| 240001539 | 240001539 | null | null | null | null | 2016-07-18 | ALL UKALL2011 Ind B Sht Dex (PAsp) | null | null | TRIAL UNSPECIFIED | 101163127 |
| 240001540 | 240001540 | null | null | null | null | 2019-02-04 | CHOP R | null | null | ALL UKALL2011 IND B | 101542529 |
| 240001543 | 240001543 | 1.66 | 74 | Curative (C) | null | 2019-11-30 | Methotrexate intrathecal | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 101584934 |
| 240001547 | 240001547 | null | 72 | Curative (C) | null | 2018-01-15 | AML 18 TRIAL | 1 | null | IMATINIB | 101558555 |
| 240001550 | 240001550 | 1.8 | 72.4 | Curative (C) | null | 2019-07-12 | Rituximab | N | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100512184 |
| 240001559 | 240001559 | 1.7 | 90 | Curative (C) | null | 2017-11-23 | Chlorambucil | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100054650 |
| 240001562 | 240001562 | null | null | null | null | 2019-11-14 | null | null | null | CYTARABINE | 101306719 |
| 240001568 | 240001568 | 1.44 | 69.2 | Curative (C) | null | 2017-11-06 | null | 02 | N | FCR | 101786170 |
| 240001570 | 240001570 | null | null | null | 2019-12-26 | 2020-01-08 | null | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101458664 |
| 240001578 | 240001578 | null | null | null | null | 2018-12-24 | null | null | null | AML18 TRIAL | 101574945 |
| 240001589 | 240001589 | 1.88 | 138 | Curative (C) | null | 2016-09-24 | null | 01 | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100797262 |
| 240001595 | 240001595 | 1.62 | 50.7 | Palliative (P) | null | 2018-09-17 | null | 02 | N | DA | 100616503 |
| 240001600 | 240001600 | 1.54 | 102.9 | 03 | null | 2019-06-26 | CYTARABINE + DAUNORUBICIN | 01 | N | CYTARABINE | 100519509 |
| 240001602 | 240001602 | null | null | null | null | 2019-05-06 | CYTARABINE + DAUNORUBICIN | null | null | UKALL2011 | 100520525 |
| 240001604 | 240001604 | 0 | 73 | Curative (C) | 2015-12-25 | 2016-02-27 | AML16 DA 3+10 | N | N | CYTARABINE | 100608628 |
| 240001607 | 240001607 | 1.75 | null | Curative (C) | null | 2016-08-12 | AML16 DA 3+10 | 02 | N | CYTARABINE + DAUNORUBICIN | 101050569 |
| 240001611 | 240001611 | 1.65 | 112.55 | Curative (C) | null | 2016-09-21 | null | 2 | N | BENDAMUSTINE + RITUXIMAB | 101240048 |
| 240001615 | 240001615 | null | null | null | null | 2017-05-24 | ANAGRELIDE | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100959324 |
| 240001616 | 240001616 | null | null | null | null | 2019-10-31 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100502502 |
| 240001622 | 240001622 | null | null | null | null | 2018-10-29 | null | 01 | null | METHOTREXATE | 101626772 |
| 240001623 | 240001623 | 1.68 | 96 | Curative (C) | null | 2018-12-17 | null | N | N | HYDROXYCARBAMIDE | 101821756 |
| 240001624 | 240001624 | null | 85.7 | Palliative (P) | null | 2017-07-13 | null | 2 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100035056 |